The European Union (EU) has introduced a new process to label medicines that are being monitored particularly closely by regulatory authorities. These medicines are described as being under ‘additional monitoring‘.
More information
- Published on 1 Oct 2013 by emainfo channel.
- EMA Medicines under additional monitoring webpage, PDF1 and PDF2, 2013.
- Watch more drugs and media videos on @DES_Journal YT channel
Interesting!
thanks
Reblogged this on Milieunet.
Erik
cheers Erik